AlphaYouJH
Congress trade
Sen. John Hoeven (R-ND) sold $100K-$250K of AbbVie Inc. (NYSE) (ABBV) stock
John Hoeven, U.S. Senator (R-ND), disclosed a sale of AbbVie Inc. (NYSE) (ABBV) stock worth $100K-$250K in a STOCK Act filing on Oct 22, 2014.
The trade happened on Sep 29, 2014, 23 days before it was made public.
ABBV has moved +349.2% since the trade date, from $58.52 to $262.90 (Oct 2, 2026 close).
- Traded
- Sep 29, 2014
- Disclosed
- Oct 22, 2014
- Filing delay
- 23 days
- Price since
- +349.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (4)
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.